html5-img
1 / 5

Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019

Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.<br> <br>Inquire for more information @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=407765 <br>

paulnelson74
Download Presentation

Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: July 2015 Single User PDF: US$ 3000 Corporate User PDF: US$ 4500 © ReportsnReports.com / Contact sales@reportsandreports.com

  2. Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019 The analysts forecast global IHD drugs market to grow at a CAGR of 3.61% during 2014-2019.IHD is an abnormal condition of the human body marked by narrowing or blocking of the arteries that supply blood to the heart. It results from the buildup of plaque in the arteries. The condition often arises during excitement and exertion when heart requires more blood supply. This leads to recurrent chest pain and discomfort due to lack of sufficient blood supply, a condition known as angina pectoris. Prolonged blockage of the arteries due to lack of blood supply may result in death of tissues in the heart, leading to myocardial infarction. The symptoms develop slowly, and in most cases the condition is asymptomatic until it reaches the last stages. The common indications include chest pain and shortness of breath. Treatment options are available depending on the condition of the patient. A range of medications of different classes, such as statins, antiplatelet drugs, nitrates, beta-blockers, etc. can be chosen from. Surgical procedures, such as angioplasty and coronary artery bypass graft, are also opted in serious scenarios. Purchase a Copy of the Report @ http://www.reportsnreports.com/Purchase.aspx?name=407765 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  3. Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019 Covered in this Report The report covers the present scenario and the growth prospects of the global IHD drugs market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the sales of various branded therapies and generics, along with the drugs used as off-label for the treatment of IHD. IHD includes: Angina pectoris Myocardial infarction. The report, namely Global IHD Drugs Market 2015-2019, is based on an in-depth market analysis, with inputs from industry experts. We covers the Americas, APAC and EMEA markets. We also discuss the key vendors operating in this market. Inquire for this report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=407765 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  4. Key Vendors - AstraZeneca plc, Bayer AG, Eli Lilly and Co., Novartis AG, Pfizer Inc. and Sanofi SA Other Prominent Vendors Actelion Amgen Baxter BoehringerIngelheim Bristol-Myers Squibb Daiichi-Sankyo Eisai F.Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Human Stem Cells Institute Janssen Pharmaceuticals Other Prominent Vendors Janssen Pharmaceuticals Juventas Therapeutics Lacer Merck Nuo Therapeutics Ono Pharmaceutical Pharmahungary Group Resverlogix Takeda Pharmaceutical Company TaxusCardium The Medicines Company United Therapeutics Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019 • Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=407765 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  5. Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019 Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Complete Report Available @ http://www.reportsnreports.com/reports/407765-global-ischemic-heart-disease-ihd-drugs-market-2015-2019.html Special Offer on Technavio/ Infiniti Reports (http://www.reportsnreports.com/publisher/infiniti-research-limited/): Buy 3 reports at the coast of 2 (Lowest Priced Report will be free) Buy 4 and more reports and get 50% flat discount on the total Price Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

More Related